×
About 1,803 results

ALLMedicine™ Oral Lichen Planus Center

Research & Reviews  604 results

Glutamine promotes the proliferation of epithelial cells via mTOR/S6 pathway in oral li...
https://doi.org/10.1111/jop.13391
Journal of Oral Pathology & Medicine : Official Publicati... Hu J, Ling Z et. al.

Dec 3rd, 2022 - Although abnormal cell proliferation and apoptosis are associated with the pathogenesis of OLP, the exactly mechanism of which is not yet known. It has been reported that glutamine (Gln) can promote cell proliferation and inhibit apoptosis of vari...

Disease severity scoring systems in mucosal lichen planus: a systematic review.
https://doi.org/10.1111/odi.14447
Oral Diseases; Unnikrishnan SP, Rampersaud E et. al.

Nov 21st, 2022 - Several scoring systems have been developed to evaluate disease severity in mucosal lichen planus, but only a few have been validated to ensure reproducible and accurate assessment of disease severity. The current systematic review was undertaken ...

Lymphocyte and CD62E expression in lichen planus and lichenoid reaction.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670570
BMC Oral Health; Werneck JT, Souza Gonçalves L et. al.

Nov 19th, 2022 - It is difficult to distinguish the clinical and histopathological aspects of oral lichen planus lesions from those of oral lichenoid reaction. Some criteria were proposed to distinguish them, mainly because they have different biological behaviors...

Oral lichen planus and related lesions. What should we accept based on the available ev...
https://doi.org/10.1111/odi.14438
Oral Diseases; González-Moles MÁ, Ramos-García P

Nov 14th, 2022 - Recent new terminologies have been proposed for lesions in the sphere of oral lichen planus (OLP) that theoretically present unique aetiological, clinical, prognostic or management characteristics different from those of the so-called typical form...

Synergistic Efficacy of Plaque Control with Intralesional Triamcinolone Acetonide Injec...
https://doi.org/10.3390/ijerph192113787
International Journal of Environmental Research and Publi... Zhao W, Lin D et. al.

Nov 12th, 2022 - This study is the first time to assess the synergistic efficacy and safety of plaque control on erosive non-gingival oral lichen planus (OLP). A randomized, controlled, clinical trial with blind evaluation was designed, and 48 OLP patients with er...

see more →

Clinicaltrials.gov  76 results

Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Triamcinolone in OLP
https://clinicaltrials.gov/ct2/show/NCT05401201

Aug 30th, 2022 - Oral Lichen Planus (OLP) is a relatively common, chronic immune-mediated mucocutaneous disease,that usually occurs on the oral mucosa surfaces. Oral lesions are commonly multiple with a bilateral and symmetrical localization. Most affected sites i...

the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in Oral Lichen Planus Patients
https://clinicaltrials.gov/ct2/show/NCT05400057

Jun 10th, 2022 - Oral lichen planus is one of the most common prevalent muco-cutaneous chronic diseases. The disease is definitely auto-immune type .Despite having idiopathic etiology, many risk factors can be considered including systemic diseases, psychogenic di...

Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases
https://clinicaltrials.gov/ct2/show/NCT05403216

Jun 3rd, 2022 - On the basis of previous studies, a validation cohort will be established to explore the relationship between oral lichen planus and autoimmune thyroid diseases, and a disease efficacy prediction strategy can be formed.

Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus
https://clinicaltrials.gov/ct2/show/NCT05330572

Apr 15th, 2022 - PARTICIPANT SELECTION AND ENROLMENT IDENTIFYING PARTICIPANTS All participants will be selected from attendants of the Oral & Maxillofacial Unit, Women's Day Clinic and Aberdeen Dental School in the Foresterhill Campus. The research team will ident...

Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
https://clinicaltrials.gov/ct2/show/NCT04364555

Apr 13th, 2022 - The investigators want to study the effect of clobetasol in symptomatic oral lichen planus. The investigators will include 90 patients and randomly allocate them in three groups. The first group will receive active treatment both in the morning an...

see more →

News  28 results

A 31-year-old female presented with a burning rash on upper arms, groin, and axillae
https://www.mdedge.com/dermatology/article/252869/medical-dermatology/31-year-old-female-presented-burning-rash-upper-arms
Alaa Erras, Brooke Resh Sateesh, MD

Mar 17th, 2022 - Lichen planus (LP) is a chronic, pruritic, inflammatory disease that can affect the skin, hair, nails, and mucosal surfaces. The exact cause is unknown, but possible causes include medications, dental amalgam fillings, or an autoimmune reaction.

Oral Lichen Planus Treated With Plasma Rich in Growth Factors
https://www.mdedge.com/dermatology/article/252373/autoimmune-diseases/oral-lichen-planus-treated-plasma-rich-growth-factors
Eduardo Anitua, DDS, MD, PhD, Asier Eguia, DDS, PhD et. al.

Mar 3rd, 2022 - Lichen planus is a chronic inflammatory mucocutaneous disease that usually affects the skin and/or the genital and oral mucosae. 1,2 This disease classically presents with clinical relapses or outbreaks that alternate with periods of remission or l.

Oral lichen planus prevalence estimates go global
https://www.mdedge.com/dermatology/article/215311/dermatology/oral-lichen-planus-prevalence-estimates-go-global
Richard Franki

Jan 10th, 2020 - The global prevalence of oral lichen planus just received its first-ever systematic review and meta-analysis, and the resulting estimates are 0. 89% for the general population and 0.

Oral lichen planus prevalence estimates go global
https://www.mdedge.com/familymedicine/article/215311/dermatology/oral-lichen-planus-prevalence-estimates-go-global?channel=39313
MDedge Endocrinology; Richard Franki

Jan 9th, 2020 - The global prevalence of oral lichen planus just received its first-ever systematic review and meta-analysis, and the resulting estimates are 0. 89% for the general population and 0.

Antimalarial may be effective, safe for erosive oral lichen planus
https://www.mdedge.com/dermatology/article/203365/medical-dermatology/antimalarial-may-be-effective-safe-erosive-oral?channel=39313
Andrew D. Bowser

Jun 21st, 2019 - MILAN – Hydroxychloroquine sulfate may be an effective and relatively safe treatment option for moderate to severe oral lichen planus, an investigator reported at the World Congress of Dermatology. Andrew Bowser/MDedge News Dr.

see more →

Patient Education  13 results see all →